ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology.
about
Planned caesarean section versus planned vaginal delivery for severe preeclampsiaManagement of Type 1 Diabetes in PregnancyHypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study.Increasing illness severity in very low birth weight infants over a 9-year period.Mean platelet volume: association with adverse neonatal outcome.Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomesDysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.Diagnostic utility of urine protein-to-creatinine ratio for identifying proteinuria in pregnancyStroke in pregnant and postpartum women.The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trialPlasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.Validation of the Omron M7 and Microlife 3BTO-A blood pressure measuring devices in preeclampsia.Haemorrhagic strokes in pregnancy and puerperium.A systematic review of the relationship between severe maternal morbidity and post-traumatic stress disorderShould bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension?Human infectious diseases and risk of preeclampsia: an updated review of the literature.Effect of preeclampsia on umbilical cord blood stem cells in relation to breast cancer susceptibility in the offspring.CA-125 and CRP are elevated in preeclampsia.An obesity-related FTO variant and the risk of preeclampsia in a Finnish study population.Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.The diagnosis of pre-eclampsia using two revised classifications in the Finnish Pre-eclampsia Consortium (FINNPEC) cohortIs preeclampsia associated with fetal malformation? A review and report of original research.First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening StudySerum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsiaThe effect of healthy pregnant plasma and preeclamptic plasma on the phagocytosis index of neutrophil granulocytes and monocytes of nonpregnant women.Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis.Epicardial fat tissue thickness in preeclamptic and normal pregnancies.RAS in Pregnancy and Preeclampsia and Eclampsia.Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry.Levels of oxidized LDL, estrogens, and progesterone in placenta tissues and serum paraoxonase activity in preeclampsiaFetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.The role of antioxidant vitamins in hypertensive disorders of pregnancy.Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patientsA practical approach to using spot urine protein/creatinine ratios for assessing proteinuria in pregnancyPlasma arachidonic and docosahexaenoic acids in Tunisian very low birth weight infants: status and association with selected neonatal morbidities.Evaluation of Glutathione Peroxidase 4 role in Preeclampsia.
P2860
Q24235494-E7F54A39-6EDC-4B3C-9C5B-FE245FDD0233Q26747535-09761050-CD10-4CC0-8DFB-9FC59B9C8A7EQ30769610-BEC938A8-8782-4334-ACCC-5DE35A1892DEQ33233190-23E602A5-A9C0-41CD-B1D0-41D4119331FEQ33286282-FBF9B5A8-2988-4640-89BC-CE14B018454DQ33454185-B6603DCD-1CC2-4CA1-BFBA-12F2E7005FACQ33769295-DBD652BE-DD01-41BD-BE85-95A20154ED47Q33801203-5B989256-A2E5-4AFB-A7AC-BBDC076FB6D1Q33987783-AD825B00-C015-42B6-B67C-C44E576517DBQ34024469-60D90CB9-65C4-4058-AF3B-FA8CAB62FAFAQ34116276-712EFF75-B780-4934-A46E-27AEEA8631F9Q34119026-9A249610-50DE-44E5-B389-6DECD847BD04Q34150192-17142DB5-4FFB-41F3-86F5-897CC3C98B45Q34165517-7C3878DC-5D87-4F5F-8F45-3DC8B958E1DAQ34366117-86F64B02-1AE4-4D70-8189-4BA129921CA8Q34472444-1C1072B4-ADAB-45A5-BACC-B6E00D7876B7Q34488052-15B86EE1-ECAE-4391-94E8-7F2FB6054547Q34557501-80D385BF-F672-4900-850F-674CEFCA03F4Q34918027-DE39F60D-5E2C-4538-8422-90FF4C212FBEQ34980683-E949282D-C779-49B6-898A-A6C42DC6BF13Q35550747-367D6E2C-0F88-4FB5-A1B9-FED1E2E834B8Q35827495-00D14D14-160B-4763-BF1B-59BDE25FB83DQ36062460-D71D0EEC-29DC-4394-BF50-1BAD0D11DF66Q36103309-417A23BF-54B7-46EA-885E-413E058D6373Q36160514-DB79BB86-FD95-4372-A48E-3A21A03DECF7Q36184116-DA7A4809-C561-4244-8B72-E23A742C4D38Q36185056-BAD3EB94-08AD-43C2-8E47-20EB23853518Q36189562-F6E613CA-9438-4241-8617-8FD61845E07BQ36189692-08178EFC-6401-4F65-824F-BD3C969691A7Q36245322-3BF2ADC1-FDFE-4625-A83B-3FF0F819C2C4Q36340302-C81CC1C7-5D44-4774-850B-C39C78CC2D9BQ36537709-5EBCBCC3-B84C-432D-BE8C-51CD49234CF8Q36731791-9AD6B68A-10DB-493E-B557-B80D0C8BB6B7Q36763386-51725748-363A-4B33-9024-70DFC9089FCCQ36787977-CDC7923A-024F-4E4C-9B85-B3EAD4A7727AQ37206182-9DFC94DF-51AF-4239-B82F-A8AC1037EAEEQ37206251-B607F0E8-2A61-4519-97E8-014DD083E592Q37229700-AD3DCD6C-02BD-4526-B1A7-94851FA8651AQ37261521-136DBB53-4097-48DF-8CB0-CEB63DFC45D6Q37264566-90F1C735-A1B3-460D-90C5-6E6E0CBAA332
P2860
ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
ACOG technology assessment. Ge ...... of Obstetrics and Gynecology.
@en
type
label
ACOG technology assessment. Ge ...... of Obstetrics and Gynecology.
@en
prefLabel
ACOG technology assessment. Ge ...... of Obstetrics and Gynecology.
@en
P2860
P1476
ACOG technology assessment. Ge ...... of Obstetrics and Gynecology.
@en
P2093
American College of Obstetrics and Gynecology
P2860
P356
10.1016/S0020-7292(02)80002-9
P577
2002-10-01T00:00:00Z